Higher Serum Vitamin D Levels Up Survival in Breast Cancer

Share this content:
Higher Serum Vitamin D Levels Up Survival in Breast Cancer
Higher Serum Vitamin D Levels Up Survival in Breast Cancer

THURSDAY, Nov. 10, 2016 (HealthDay News) -- Serum 25-hydroxyvitamin D levels may affect breast cancer patients' chances of survival, according to a study published online Nov. 10 in JAMA Oncology.

Song Yao, Ph.D., of the Roswell Park Cancer Institute in Buffalo, N.Y., and colleagues analyzed data from 1,666 breast cancer patients in California.

The researchers found that higher serum 25-hydroxyvitamin D levels at diagnosis were associated with better overall survival. This link was strongest in premenopausal women. The researchers also found lower 25-hydroxyvitamin D levels in patients with advanced-stage tumors and the lowest levels in premenopausal women with triple-negative cancer.

"Serum 25-hydroxyvitamin D levels were independently associated with breast cancer prognostic characteristics and patient prognosis, most prominently among premenopausal women," the authors write. "Our findings provide compelling observational evidence for inverse associations between vitamin D levels and risk of breast cancer progression and death."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »